A Phase II Study to Determine the Safety and Efficacy of INCB024360 in Patients With Myelodysplastic Syndromes
Phase of Trial: Phase II
Latest Information Update: 25 Jan 2016
Price : $35 *
At a glance
- Drugs Epacadostat (Primary)
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- 18 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 16 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Jul 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.